Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.

The paper consists of two parts. A review of the relationship of panic disorder to the phobic states and the treatment of these disorders by means of tricyclic antidepressants, MAOIs, beta blocking drugs and benzodiazepines. A double blind study of alprazolam and placebo in 118 patients with agoraphobia and panic is presented. In an eight week study alprazolam was found to be significantly superior to placebo in the treatment of panic attacks, phobic avoidance, anticipatory anxiety and general anxiety.
AuthorsR P Swinson, J C Pecknold, K Kuch
JournalProgress in neuro-psychopharmacology & biological psychiatry (Prog Neuropsychopharmacol Biol Psychiatry) Vol. 11 Issue 2-3 Pg. 105-13 ( 1987) ISSN: 0278-5846 [Print] ENGLAND
PMID3628823 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Alprazolam
  • Agoraphobia (drug therapy)
  • Alprazolam (adverse effects, therapeutic use)
  • Anxiety Disorders (drug therapy)
  • Dose-Response Relationship, Drug
  • Fear (drug effects)
  • Humans
  • Panic (drug effects)
  • Phobic Disorders (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: